Some studies have found that B-cell translocation gene 3 (BTG3) is significantly downregulated in GC, which may be related to tumour proliferation, migration, and invasion, and has potential as a biomarker for predicting the prognosis of GC patients (Ren et al., 2015). The gene discussed is BTG3; the disease is neoplasm.